216 related articles for article (PubMed ID: 16181211)
41. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
Modrof J; Berting A; Tille B; Klotz A; Forstner C; Rieger S; Aberham C; Gessner M; Kreil TR
Transfusion; 2008 Jan; 48(1):178-86. PubMed ID: 17900278
[TBL] [Abstract][Full Text] [Related]
42. Proteolytic degradation of cold-water fish gelatin solutions and gels.
Solgaard G; Haug IJ; Draget KI
Int J Biol Macromol; 2008 Aug; 43(2):192-7. PubMed ID: 18571715
[TBL] [Abstract][Full Text] [Related]
43. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
[TBL] [Abstract][Full Text] [Related]
44. Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Banazadeh S
Hum Antibodies; 2010; 19(1):1-6. PubMed ID: 20555125
[TBL] [Abstract][Full Text] [Related]
45. The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used.
Djoumerska I; Tchorbanov A; Pashov A; Vassilev T
Scand J Immunol; 2005 Apr; 61(4):357-63. PubMed ID: 15853919
[TBL] [Abstract][Full Text] [Related]
46. Effect of the conformational stability of the CH2 domain on the aggregation and peptide cleavage of a humanized IgG.
Kameoka D; Ueda T; Imoto T
Appl Biochem Biotechnol; 2011 Jul; 164(5):642-54. PubMed ID: 21279469
[TBL] [Abstract][Full Text] [Related]
47. Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution.
Reipert BM; Ilas J; Carnewal C; Füreder SF; Bölzlbauer U; Teschner W; Fiedler C; Schwarz HP
Vox Sang; 2006 Oct; 91(3):256-63. PubMed ID: 16958839
[TBL] [Abstract][Full Text] [Related]
48. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
[TBL] [Abstract][Full Text] [Related]
49. Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine.
Delatour T; Hegele J; Parisod V; Richoz J; Maurer S; Steven M; Buetler T
J Chromatogr A; 2009 Mar; 1216(12):2371-81. PubMed ID: 19181321
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
[TBL] [Abstract][Full Text] [Related]
51. An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA).
Klaamas K; Kodar K; Kurtenkov O
Neoplasma; 2008; 55(2):143-50. PubMed ID: 18237253
[TBL] [Abstract][Full Text] [Related]
52. [The physico-chemical characterization and crystallization of immunoglobulins and their fragmentation products: a contribution to the elucidation of the three-dimensional structure of antibodies, II. Human immunoglobulin Kol.: a myeloma protein of the class IgG, gamma2 kappa2, Gm (f)+ (author's transl)].
Palm W
Hoppe Seylers Z Physiol Chem; 1974 Jul; 355(7):877-80. PubMed ID: 4435759
[No Abstract] [Full Text] [Related]
53. [Contamination of IgG preparation for intravenous use with IgA. II. Removal of IgA1 from IgG preparation using affinity chomatography on lectin jacalin columns].
Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
Srp Arh Celok Lek; 1994; 122 Suppl 1():51-2. PubMed ID: 18173187
[TBL] [Abstract][Full Text] [Related]
54. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
55. Fb'2, a new peptic fragment of human immunoglobulin G.
Parr DM; Connell GE; Kells DI; Hofmann T
Biochem J; 1976 Apr; 155(1):31-6. PubMed ID: 779769
[TBL] [Abstract][Full Text] [Related]
56. Solid-phase immunoassays for HCV antibodies in Gamimune N.
Schreiner C; Musmanno L; Kuenzi M; Torres J
Vox Sang; 1998; 74(3):156-60. PubMed ID: 9595642
[TBL] [Abstract][Full Text] [Related]
57. Purification of intravenous immunoglobulin G from human plasma--aspects of yield and virus safety.
Buchacher A; Iberer G
Biotechnol J; 2006 Feb; 1(2):148-63. PubMed ID: 16892245
[TBL] [Abstract][Full Text] [Related]
58. Identification and characterization of an IgG binding protein in the secretion of the rat coagulating gland.
Wilhelm B; Keppler C; Henkeler A; Schilli-Westermann M; Linder D; Aumüller G; Seitz J
Biol Chem; 2002 Dec; 383(12):1959-65. PubMed ID: 12553734
[TBL] [Abstract][Full Text] [Related]
59. The relative rate of immunoglobulin gamma 1 fragmentation.
Kamerzell TJ; Li M; Arora S; Ji JA; Wang YJ
J Pharm Sci; 2011 Apr; 100(4):1341-9. PubMed ID: 24081469
[TBL] [Abstract][Full Text] [Related]
60. Assessment of microbial growth in intravenous immune globulin preparations.
Pfeifer RW; Siegel J; Ayers LW
Am J Hosp Pharm; 1994 Jul; 51(13):1676-9. PubMed ID: 7942893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
